Brown Brothers Harriman & CO Sarepta Therapeutics, Inc. Transaction History
Brown Brothers Harriman & CO
- $13.6 Billion
- Q1 2025
A detailed history of Brown Brothers Harriman & CO transactions in Sarepta Therapeutics, Inc. stock. As of the latest transaction made, Brown Brothers Harriman & CO holds 4,370 shares of SRPT stock, worth $175,018. This represents 0.0% of its overall portfolio holdings.
Number of Shares
4,370
Previous 4,394
0.55%
Holding current value
$175,018
Previous $534,000
47.94%
% of portfolio
0.0%
Previous 0.0%
Shares
13 transactions
Others Institutions Holding SRPT
# of Institutions
506Shares Held
88.9MCall Options Held
1.39MPut Options Held
1.13M-
Black Rock Inc. New York, NY10.3MShares$413 Million0.04% of portfolio
-
Capital International Investors Los Angeles, CA9.06MShares$363 Million0.12% of portfolio
-
Vanguard Group Inc Valley Forge, PA9.03MShares$362 Million0.01% of portfolio
-
State Street Corp Boston, MA4.07MShares$163 Million0.01% of portfolio
-
Janus Henderson Group PLC London, X03.36MShares$135 Million0.12% of portfolio
About Sarepta Therapeutics, Inc.
- Ticker SRPT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 87,567,904
- Market Cap $3.51B
- Description
- Sarepta Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery and development of RNA-targeted therapeutics, gene therapies, and other genetic therapeutic modalities for the treatment of rare diseases. It offers EXONDYS 51 injection to treat duchenne muscular dystrophy (duchenne) in patients with confirmed mut...